Lively and interactive, AMCP Partnership Forums bring together key decision-makers in managed care, integrated care networks, the pharmaceutical industry, and other vital sectors to discuss and collaborate on strategies to drive efficiency and improve patient outcomes. Designed to address current market challenges and opportunities, AMCP Partnership Forums also:
- Take a proactive, collaborative approach to solving critical issues and challenges.
- Gain consensus on challenges or opportunities to remove barriers to improve patient care and optimize value for all stakeholders.
- Represent opportunities for payers, manufacturers, patients, and other stakeholders to work together on common goals and interests and create actionable results.
- Experience high visibility among industry stakeholders and policymakers.
Recent Partnership Forums:
Patient Input and Payer Decision-Making
Dec. 6–7, 2023 | Old Town Alexandria, VA
There has been growing consensus in recent years for health care to become more “‘patient-centric” by including consideration of patient preferences, needs, and values in clinical decision-making. Some examples include the Food and Drug Administration’s patient-focused drug development program, quality measures that increasingly include patient-reported outcome measures, and providers and patients using shared-decision making tools to discuss treatment options. To assess population health decisions, particularly in managed care pharmacy, there have been increasing calls for scientifically generated patient information to supplement existing evidence for the assessment of value and coverage decisions with outcomes that matter to patients. In both the US and globally, there are health technology assessment groups that engage patients when assessing value. In addition, many US states require patients to be included in their Medicaid DUR boards. This Partnership Forum will serve to initiate a discussion about the development of a framework for health plans/payers to engage patient advocacy organizations in managed care pharmacy decision-making.
This Partnership Forum will seek to identify the value of collaboration between health plans/payers and patient advocacy organizations in managed care pharmacy decision-making. Participants will discuss barriers and potential solutions to collaboration and provide insight into tools that have been developed to optimize partnerships across organizations.
Past Partnership Forums:
Watch highlights from a recent Partnership Forum
View more past Partnership Forums.
ADVISORY GROUP — Addressing Barriers to Value-Based Payment Models in Integrated Delivery Networks
Collaborate with a group of key stakeholders to address how existing laws are impacting integrated delivery networks (IDNs) and pharmaceutical partnerships. Legal and regulatory requirements (e.g., the Anti-Kickback Statute and Medicaid best price rule) can limit the use of certain strategies that could potentially improve care coordination and patient outcomes. Successful implementation of value-based agreements in IDNs requires a range of complex capabilities. The workgroup will provide examples of real-world challenges and possible solutions that will inform and support efforts for legislative change.
ADVISORY GROUP — Substance Use Disorder: A Focus on Prescription Drug Use
Despite efforts to decrease the use of opioids, challenges remain. AMCP created multiple advisory groups beginning in 2015 recognizing the widespread and devastating nature of the opioid crisis. Over time, these groups addressed access to medications for treatment of substance use disorders and developed a viewpoint document on the importance of co-prescribing naloxone. The purpose of this group is to continue the work of the previous groups and focus on collecting and disseminating guidelines for managed care pharmacists regarding integrated care models and benefit designs that effectively address substance use disorder.
ADVISORY GROUP — Health Disparities
Now more than ever, there is an increased focus on health disparities that occur across a multitude of factors, including socioeconomic status, ethnicity, and race. As part of AMCP's strategic priority on addressing health disparities and commitment to transition from awareness to action, AMCP is committed to leveraging managed care pharmacy to address disparities in benefit design, medication use and outcomes in underserved populations. This advisory group will build upon the recommendations put forth during AMCP's 2021 Partnership Forum and will provide guidance as AMCP works to create awareness on the role of managed care professionals in this area, identify partners, and develop tools and resources to aid managed care pharmacy transition from awareness to action.
ADVISORY GROUP — Digital Therapeutics
The role of digital therapeutics in preventing, managing, and treating medical conditions continues to evolve, offering the potential for therapeutic benefit. AMCP is committed to leveraging managed care pharmacy to continue to evolve the use of digital therapeutics to improve patient care and outcomes. This group will build upon the recommendations put forth during the previous AMCP Partnership Forums and provide guidance to AMCP in its efforts to establish the leadership role of managed care pharmacy professionals in this area, identify potential partners, and assist in the creation and dissemination of tools and resources to enhance the coverage and utilization of digital therapeutics.